Free Trial

8,124 Shares in Proto Labs, Inc. (NYSE:PRLB) Acquired by Summit Global Investments

Proto Labs logo with Industrials background
Remove Ads

Summit Global Investments acquired a new position in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,124 shares of the industrial products company's stock, valued at approximately $318,000.

Several other hedge funds have also recently bought and sold shares of PRLB. Modus Advisors LLC acquired a new stake in Proto Labs in the fourth quarter valued at approximately $87,000. Point72 Asia Singapore Pte. Ltd. increased its holdings in Proto Labs by 40.6% in the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,108 shares of the industrial products company's stock worth $121,000 after purchasing an additional 1,186 shares in the last quarter. Paloma Partners Management Co acquired a new stake in Proto Labs during the 3rd quarter worth approximately $201,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in Proto Labs during the 4th quarter worth approximately $205,000. Finally, Intech Investment Management LLC bought a new position in shares of Proto Labs during the third quarter valued at $232,000. 84.54% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on PRLB. Needham & Company LLC reiterated a "hold" rating on shares of Proto Labs in a report on Friday, February 7th. Cantor Fitzgerald upped their price target on shares of Proto Labs from $40.00 to $50.00 and gave the company an "overweight" rating in a research report on Monday, February 10th. Finally, StockNews.com raised shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $43.67.

Remove Ads

Read Our Latest Report on PRLB

Proto Labs Price Performance

Shares of PRLB stock traded down $1.27 on Friday, hitting $35.78. The stock had a trading volume of 136,574 shares, compared to its average volume of 223,178. Proto Labs, Inc. has a 12-month low of $25.76 and a 12-month high of $46.73. The business has a 50 day moving average of $39.89 and a 200 day moving average of $36.88. The stock has a market cap of $867.11 million, a price-to-earnings ratio of 55.05 and a beta of 1.45.

Proto Labs declared that its Board of Directors has authorized a share buyback program on Friday, February 7th that authorizes the company to repurchase $100.00 million in outstanding shares. This repurchase authorization authorizes the industrial products company to purchase up to 9.8% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board believes its shares are undervalued.

About Proto Labs

(Free Report)

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.

Read More

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Should You Invest $1,000 in Proto Labs Right Now?

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 International Stocks to Escape U.S. Market Volatility

5 International Stocks to Escape U.S. Market Volatility

MarketBeat’s Chris Markoch shares 5 international stock picks that could offer protection—and potential opportunity—amid the current market uncertainty.

Related Videos

3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads